A roadmap for translational cancer glycoimmunology at single cell resolution
Abstract Cancer cells can evade immune responses by exploiting inhibitory immune checkpoints.Immune checkpoint inhibitor (ICI) therapies based on anti-CTLA-4 and anti-PD-1/PD-L1 antibodies Dryer Belt Break Switch have been extensively explored over the recent years to unleash otherwise compromised anti-cancer immune responses.However, it is also we